IMCIROMAB
UNII UT2BA2O3KN

Substance Identification & Data

This profile provides standardized clinical and technical data for Imciromab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UT2BA2O3KN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 126132-83-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UT2BA2O3KN
CAS Registry Number
126132-83-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IMCIROMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
6605
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imciromab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMCIROMAB

Common Names & Synonyms

IMCIROMAB [INN]
IMCIROMAB [WHO-DD]